FDA
- Status: approved
Triple combination therapy (Triple combination therapy) regulatory status in United States.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA has authorised it.
National Jewish Health is the originator. The local marketing authorisation holder may differ — check the official source linked above.